Clinical Trial Update: Trial to Assess the Efficacy of Midostaurin (PKC412) in Patients With c-KIT or FLT3-ITD Mutated t(8;21) AML [Phase 2]

View source ↗

Summary

Phase 2 trial assessing midostaurin in acute myeloid leukemia with specific c-KIT or FLT3-ITD mutations; study status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• Midostaurin (midostaurin)

Snippet

Sponsor: Technische Universität Dresden | Conditions: Acute Myeloid Leukemia | Phase 2 | Status: COMPLETED